Publication
This publication explores how lenalidomide may enhance the activity of CD1d-Vδ2 bispecific antibody-engaged Vγ9Vδ2 T cells. The work adds to the scientific foundation for combining unconventional T cell engagement with established treatment modalities.
Read the publication →